Novo Nordisk A/S (Novo Nordisk A/S) Change In Inventory

: $0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1981. Start your Free Trial

Novo Nordisk A/S's change in inventory for the quarter that ended in Dec. 2023 was $0 Mil. It means Novo Nordisk A/S's inventory stayed the same from Sep. 2023 to Dec. 2023 .

Novo Nordisk A/S's change in inventory for the fiscal year that ended in Dec. 2023 was $-1,086 Mil. It means Novo Nordisk A/S's inventory increased by $1,086 Mil from Dec. 2022 to Dec. 2023 .

Novo Nordisk A/S's Total Inventories for the quarter that ended in Dec. 2023 was $4,654 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Novo Nordisk A/S's Days Inventory for the quarter that ended in Dec. 2023 was 276.55.

Inventory Turnover measures how fast the company turns over its inventory within a year. Novo Nordisk A/S's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.33.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novo Nordisk A/S's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.46.

Novo Nordisk A/S Change In Inventory Historical Data

The historical data trend for Novo Nordisk A/S's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

-194.11

-146.35

-164.87

-678.78

-1,086.06

Novo Nordisk A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory																-	-	-	-	-

Novo Nordisk A/S Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Novo Nordisk A/S (NYSE:NVO) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Novo Nordisk A/S's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	4440.4195	/	1465.149	*	365 / 4
	=	276.55

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Novo Nordisk A/S's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1465.149	/	4440.4195
	=	0.33

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Novo Nordisk A/S's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	4440.4195	/	9636.42
	=	0.46

Novo Nordisk A/S Change In Inventory Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (NYSE:NVO) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

NONOF:USA NOVOB:Mexico NVO:Mexico NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, DK-2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.